Rare Lung Cancer Complication Causes Tumors to Replace Bones

A 55-year-old man in Australia has faced a rare and alarming complication of metastatic squamous-cell lung cancer, which resulted in tumors completely replacing the bones in his fingers and toes. Initially attributing the painful swelling in his right middle finger and right big toe to a minor issue, he learned that his condition was far more serious after seeking medical attention.

The man was diagnosed with an aggressive form of lung cancer that starts in the flat, thin cells lining the airways, making up approximately 25 percent of all lung cancer cases, or about 58,000 diagnoses annually in the United States alone. After noticing the club-like shape of his swollen digits, he visited a local hospital six weeks later, where doctors documented his case in a medical journal.

Upon examination, doctors found that the tips of his affected fingers and toe were red, swollen, and sensitive to touch. An ulcer had developed near the nail of his toe, causing it to turn bright yellow. Imaging scans revealed “destructive lytic lesions,” indicating that the bone tissue had been destroyed and replaced by tumors.

Using a radiograph, physicians diagnosed him with acrometastasis, a rare occurrence where cancer spreads to bones in the hands and feet, below the elbow or knee. This condition accounts for only about 0.1 percent of cancer cases that have metastasized to the bones. While acrometastases are generally seen in patients already diagnosed with cancer, in some cases, they can be the initial signs of undiagnosed conditions, including cancers of the lung and gastrointestinal tract.

Acrometastases are notably more prevalent in men, largely due to the higher incidence of lung cancer in this demographic. The symptoms often mimic those of gout or osteomyelitis, resulting in inflammation, redness, and swelling. The rarity of acrometastases may stem from the fact that cancer cells typically migrate to areas with more bone marrow, such as the long bones of the body. In contrast, the bones in fingers and toes contain significantly less marrow, making them less likely targets.

Additionally, the distance from the heart plays a role in the prevalence of acrometastases. Bones further from the heart receive less blood flow, complicating the ability of cancer cells to reach the extremities. Unfortunately, the prognosis for patients with acrometastasis is grim; they are often already in advanced stages of cancer, with survival times averaging less than six months post-diagnosis.

In this case, doctors initiated treatment with palliative radiotherapy, aimed at relieving pain from the cancer’s spread to the bone. Tragically, the man succumbed to refractory hypercalcemia three weeks later, a condition characterized by dangerously high calcium levels in the blood that commonly complicates cancer cases.

This case highlights the critical importance of recognizing unusual symptoms in cancer patients and the need for thorough diagnostic evaluations to address potential complications effectively.